SEC Form 4 · accession 0001651844-15-000008

NYMOX PHARMACEUTICAL CORP · NYMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 14, 2015

Accepted (ET)

Dec 18, 2015 · 5:46 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001018735

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Dec 14, 2015	P	3,188	$3.53	A	2,427,550	D
Common Stock	Dec 14, 2015	P	10,000	$3.47	A	2,437,550	D
Common Stock	Dec 14, 2015	P	10,000	$3.42	A	2,447,550	D
Common Stock	Dec 15, 2015	P	9,946	$3.40	A	2,457,496	D
Common Stock	Dec 15, 2015	P	10,000	$3.43	A	2,467,496	D
Common Stock	Dec 16, 2015	P	200	$3.46	A	2,467,696	D
Common Stock	Dec 17, 2015	P	8,600	$3.97	A	2,476,296	D
Common Stock	Dec 17, 2015	P	1,300	$3.96	A	2,477,596	D
Common Stock	Dec 17, 2015	P	100	$3.95	A	2,477,696	D
Common Stock	Dec 18, 2015	P	10,000	$3.68	A	2,487,696	D
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust
Common Stock	holding	—	—		—	45,050	I	Trust

No Table II lines on this filing.